DURANTE MANGONI, Emanuele
 Distribuzione geografica
Continente #
EU - Europa 11.400
NA - Nord America 8.066
AS - Asia 6.961
SA - Sud America 1.332
AF - Africa 98
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 8
Totale 27.881
Nazione #
US - Stati Uniti d'America 7.950
RU - Federazione Russa 4.935
SG - Singapore 2.763
IE - Irlanda 1.940
HK - Hong Kong 1.476
CN - Cina 1.380
BR - Brasile 1.131
UA - Ucraina 1.099
GB - Regno Unito 902
IT - Italia 735
SE - Svezia 489
DE - Germania 418
VN - Vietnam 335
FI - Finlandia 329
KR - Corea 286
TR - Turchia 237
GR - Grecia 192
IN - India 145
FR - Francia 144
JP - Giappone 103
AR - Argentina 87
AT - Austria 75
MX - Messico 46
CA - Canada 42
BD - Bangladesh 40
EC - Ecuador 35
ZA - Sudafrica 32
ID - Indonesia 31
IQ - Iraq 28
BE - Belgio 24
NL - Olanda 24
UZ - Uzbekistan 20
MA - Marocco 18
ES - Italia 17
EU - Europa 16
CO - Colombia 15
PK - Pakistan 15
PY - Paraguay 15
VE - Venezuela 15
CL - Cile 14
KE - Kenya 14
EG - Egitto 12
JO - Giordania 11
PL - Polonia 11
MK - Macedonia 10
SA - Arabia Saudita 10
AE - Emirati Arabi Uniti 9
JM - Giamaica 8
AL - Albania 7
KZ - Kazakistan 7
LT - Lituania 7
PE - Perù 7
PH - Filippine 7
TN - Tunisia 7
UY - Uruguay 7
AU - Australia 6
BG - Bulgaria 6
BO - Bolivia 6
MY - Malesia 6
NP - Nepal 6
PT - Portogallo 6
TT - Trinidad e Tobago 6
DZ - Algeria 5
HN - Honduras 5
AZ - Azerbaigian 4
BH - Bahrain 4
CH - Svizzera 4
CZ - Repubblica Ceca 4
IL - Israele 4
IR - Iran 4
KG - Kirghizistan 4
LB - Libano 4
TW - Taiwan 4
DK - Danimarca 3
ET - Etiopia 3
KW - Kuwait 3
RO - Romania 3
RS - Serbia 3
TH - Thailandia 3
AM - Armenia 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
HU - Ungheria 2
LK - Sri Lanka 2
LV - Lettonia 2
NG - Nigeria 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
OM - Oman 2
PA - Panama 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
BF - Burkina Faso 1
BW - Botswana 1
CY - Cipro 1
EE - Estonia 1
GT - Guatemala 1
HR - Croazia 1
LY - Libia 1
Totale 27.873
Città #
Dublin 1.936
Jacksonville 1.673
Moscow 1.601
Hong Kong 1.476
Santa Clara 1.146
Singapore 1.023
Chandler 1.011
Princeton 336
Roxbury 274
Seoul 273
Ashburn 230
Hefei 214
Cambridge 207
Boardman 188
Woodbridge 171
Beijing 144
New York 139
Ann Arbor 135
Medford 134
Dallas 132
The Dalles 130
Wilmington 124
Ho Chi Minh City 114
Bengaluru 97
Mountain View 85
Nuremberg 85
São Paulo 85
Des Moines 66
Hanoi 63
San Mateo 63
Naples 56
Nanjing 51
Munich 46
Jinan 40
Lappeenranta 39
Belo Horizonte 34
Marano Di Napoli 32
Rio de Janeiro 32
Los Angeles 30
Vienna 29
Düsseldorf 28
Norwalk 26
Brussels 24
Changsha 22
Milan 22
Shenyang 22
Guangzhou 21
Falkenstein 20
Houston 19
Bremen 18
Helsinki 18
Porto Alegre 18
Brasília 17
Haiphong 17
Nanchang 17
Tashkent 17
Tianjin 17
Toronto 17
Brooklyn 16
Washington 16
Da Nang 15
Dhaka 15
Kunming 15
Salvador 15
Curitiba 14
San Francisco 14
Taiyuan 14
Venice 14
Zhengzhou 14
Bologna 13
London 13
Quito 13
Rome 13
Shanghai 13
Boston 12
Hebei 12
Johannesburg 12
Nairobi 12
Amman 11
Campinas 11
Caserta 11
Chicago 11
Guayaquil 11
Hangzhou 11
Ningbo 11
Ribeirão Preto 11
Seattle 11
Viterbo 11
Casablanca 10
Guadalupe 10
Joinville 10
Napoli 10
Ninh Bình 10
Amsterdam 9
Atlanta 9
Baghdad 9
Cape Town 9
Caxias do Sul 9
Council Bluffs 9
Franca 9
Totale 14.602
Nome #
Endocardite infettiva (EI) nei tossicodipendenti ( IVDU): prevalenza del coinvolgimento del cuore sinistro e cambiamenti del profilo microbiologico 220
Anti-envelope 1 and 2 immune response in chronic hepatitis C patients: Effects of hepatitis B virus co-infection and interferon treatment 142
Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration 133
Antistaphylococcal β-Lactams versus Vancomycin for Treatment of Infective Endocarditis Due to Methicillin-Susceptible Coagulase-Negative Staphylococci: a Prospective Cohort Study from the International Collaboration on Endocarditis 127
Anticorpi anti-fosfolipidi nell’endocardite infettiva: possibile ruolo nel determinismo delle complicanze emboliche 121
Association between surgical indications, operative risk, and clinical outcome in infective endocarditis: a prospective study from the International Collaboration on Endocarditis. 117
Alterazioni istopatologiche epatiche in pazienti con cardiomiopatia dilatativa: prevalenza e correlazioni con l’etiologia della patologia cardiaca 117
A case of destructive infective endocarditis 115
Endocardite Infettiva da Streptococcus bovis: risultati dello Studio Endocarditi Italiano (SEI) 112
20210 G/A prothrombin gene mutation in patients with ischemic heart disease 112
Cardiac sequelae after coronavirus disease 2019 recovery: a systematic review 112
A preliminary randomized study of growth hormone administration in Becker and Duchenne muscular dystrophies 110
A case of coagulopathy of unclear definition 109
Acute kidney injury during colistin therapy: a prospective study in patients with extensively-drug resistant Acinetobacter baumannii infections 108
Nocardiosi polmonare in pazienti con trapianto di cuore: casi clinici 106
Yellow nail syndrome as a cause of unexplained edema 105
Alterazioni istopatologiche epatiche in pazienti con cardiomiopatia dilatativa: prevalenza e correlazioni con l’etiologia della patologia cardiaca 105
Adefovir treatment for chronic hepatitis B in heart transplant recipients. 105
Caratteristiche attuali dell'endocardite infettiva in Italia: risultati dello Studio Endocarditi Italiano (SEI) 103
Clinical efficacy and safety of cefiderocol for resistant gram-negative infections: a real-life, single center experience 101
. Cinetica precoce dell’HCV-RNA in pazienti con epatite cronica: correlati clinico-virologici e valore predittivo la risposta al trattamento antivirale 101
Antibiotic treatment of infections caused by carbapenem-resistant Gram-negative bacilli: an international ESCMID cross-sectional survey among infection diseases specialists practicing in large hospitals 101
Impact of early valve surgery on outcome of Staphylococcus aureus prosthetic valve infective endocarditis: analysis in the International Collaboration of Endocarditis-Prospective Cohort Study. 99
Can we go for a shorter treatment course in chronic hepatitis C? More inspiring cases 99
COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study 99
Three-phase sequential combined treatment with lamivudine and interferon in young patients with chronic hepatitis B 98
Celiachia silente in pazienti con epatite C: prevalenza, effetto del trattamento con alfa-interferone sull’attivazione della malattia ed evoluzione clinica 98
Does this patient have COVID-19? A practical guide for the internist 98
Effects of growth hormone therapy in Becker patients with dilated cardiomyopathy 97
Infective endocarditis due to high-level gentamicin and glycopeptides resistant enterococci: efficacy of the ampicillin-fluoroquinolones combination 97
Epatopatia cronica ed endocardite infettiva: risultati dello studio endocardite italiano (SEI) 97
Treatment of pulmonary nocardiosis in heart-transplant patients: importance of susceptibility studies 96
Anticorpi anti-fosfolipidi nell’endocardite infettiva: possibile ruolo nel determinismo delle complicanze emboliche 96
Ruolo patogenetico dell'adiponectina nella steatosi associata ad epatite C 96
Colistin plus meropenem for carbapenem-resistant Gram-negative infections: in vitro synergism is not associated with better clinical outcomes 96
Viral Hepatitis C 96
A European first: Successful heart transplant in a human immunodeficiency virus-positive recipient 95
Leukocyte interferon-alpha and ribavirin for treatment of chronic hepatitis C patients intolerant to pegylated-interferon 94
Right diaphragm paralysis following cardiac radiofrequency catheter ablation for inappropriate sinus tachycardia 94
Differential expression of toll-like receptor mRNA in treatment non-responders and sustained virologic responders at baseline in patients with chronic hepatitis C 94
Embolia maggiore nell’endocardite infettiva: associazione con l’età e la risposta di fase acuta 94
Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-alpha in chronic hepatitis C patients 93
Infezioni polmonari micotiche e da nocardia nel paziente cardiotrapiantato: caratteristiche cliniche e trattamento 93
Comunicazione orale: Cinetica precoce dell’HCV-RNA in pazienti con epatite cronica: correlati clinico-virologici e valore predittivo la risposta al trattamento antivirale 93
Growth hormone deficiency in patients with Duchenne/Becker muscular dystrophy: association with dilated cardiomyopathy 93
Association Between Valvular Surgery and Mortality Among Patients With Infective Endocarditis Complicated by Heart Failure 93
The value of open-source clinical science in pandemic response: lessons from ISARIC 93
Insulin resistance and steatosis in HBV-HCV co-infected patients: Role of PNPLA3 polymorphisms and impact on liver fibrosis progression. 92
Factor V Leiden and glycoprotein IIIa PlA2 polymorphism in coronary thrombosis 92
Cardiovascular Risk in Patients with Chronic Hepatitis C Treated with Direct Acting Antivirals 91
Clinical results with the use of ceftaroline and ceftobiprole: real-life experience in a tertiary care hospital 91
Rhodococcus equi as a cause of Infective Endocarditis: description of 2 clinical cases 91
Interferon-induced anti-HBE seroconversion correlates with a Th1 cytokine shift following emergence of core promoter mutations in chronic hepatitis B 90
Short-term effective bactericidal treatment of pulmonary nocardiosis in heart-transplant patients: importance of susceptibility studies 90
Clinical Characteristics and Outcome of MDR/XDR Bacterial Infections in a Neuromuscular Semi-Intensive/Sub-Intensive Care Unit 89
Ruolo dell’asse GH/IGF-1 nella fisiopatologia e nella terapia cardiovascolare: lezioni da studi sull’animale 89
. Iperomocisteinemia in pazienti con cardiomiopatia dilatativa: relazione con i parametri di funzione cardiaca e ruolo dei polimorfismi genici predisponenti 89
Clinical significance and prognostic value of hemostasis parameters in 337 patients with acute infective endocarditis 89
Thrombotic and hemorrhagic complications of COVID-19 in adults hospitalized in high-income countries compared with those in adults hospitalized in low- and middle-income countries in an international registry 88
Mild chronic hepatitis C with steatosis: Which treatment? 88
Infective endocarditis on cardiac rhythm management devices: preliminary study on the possible pathogenic role of inherited thrombophilias 88
Associating enterococcal endocarditis and colorectal neoplasia: is colonoscopy mandatory? – Authors’ reply 88
Ruolo patogenetico dell’adiponectina nella steatosi associata ad epatite C 87
Comunicazione orale: Association of plasma homocysteine levels with infective endocarditis. 87
Efficacia e sicurezza della combinazione colistina-rifampicina in confronto con la colistina in monoterapia nelle infezioni gravi da Acinetobacter baumannii MDR: risultati preliminari 87
Utilità dell'esame colturale ed isto-patologico della valvola nell'endocardite infettiva 87
Emerging Concepts on Infection of Novel Cardiac Implantable Devices 86
Association of Country Income Level With the Characteristics and Outcomes of Critically Ill Patients Hospitalized With Acute Kidney Injury and COVID-19 86
Risk factors for "major" embolic events in hospitalized patients with infective endocarditis 86
Features of infective endocarditis in persons on chronic hemodialysis. Results from the prospective, observational SEI study (Italian Study on Endocarditis) 86
Report on 509 defined cases of infectious endocarditis of the multicentric italian study (SEI) 86
Oral presentation: Treatment of Duchenne dystrophy: results of 7 years cloprednol oral administration 86
Growth hormone evaluation in patients with dystrophinopathic muscular dystrophy and dilated cardiomyopathy 86
Management of carbapenem resistant Enterobacteriaceae infections 86
Risk factors and outcome of multidrug-resistant infections after heart transplant: A contemporary single center experience 86
Defective synthesis of granulocyte-colony stimulating factor in pegylated interferon-alpha treated chronic hepatitis C patients with declining leukocyte counts 85
Factor V Leiden in patients with acute coronary syndromes 85
Significance of HCV RNA and HCV core antigen kinetics during antiviral therapy for chronic hepatitis C 85
Factors affecting hospital mortality in critically ill patients with multi-drug resistant Acinetobacter baumannii 85
Mutato spettro clinico della endocardite infettiva in persone tossicodipendenti 85
Correlation of serum HBeAg levels and double A1762T/G1764A HBV core promoter mutation with response to interferon in patients with chronic hepatitis B 85
Viability of pegIFNα-RBV for CHC in the direct acting antiviral era: a practical algorithm between efficacy and cost containment 85
Prognostic Value of Decreased High-Density Lipoprotein Cholesterol Levels in Infective Endocarditis 85
Oral presentation: Clinical characteristics and 1 year outcome of cardiac device infective endocarditis 84
Oral presentation: Clinical features and outcome of patients with vascular prostheses infection 84
Unusually high rate of hepatic comorbidity with Streptococcus bovis endocarditis: trend or coincidence? 84
Heart failure in infective endocarditis: a report from the multicenter, prospective, observational Study on Endocarditis in Italy (SEI) 84
Inherited thrombophilia as a risk factor for infective endocarditis on cardiac rhythm management devices 84
Predictors of long-term mortality in left-sided infective endocarditis: an historical cohort study in 414 patients 84
Microsomal triglyceride transfer protein (MTP) -493G/T gene polymorphism contributes to fat liver accumulation in HCV genotype 3 infected patients 83
Sicurezza ed efficacia del trattamento con Peg-interferone e Ribavirina in pazienti con epatite C e cardiopatia strutturale 83
Long-Term Outcome of Infective Endocarditis Involving Cardiac Implantable Electronic Devices: Impact of Comorbidities and Lead Extraction 82
Management of Gram-negative and fungal endocarditis 82
In-hospital and 1-year mortality in patients undergoing early surgery for prosthetic valve endocarditis. 82
Global spread of drug-resistant Acinetobacter baumannii: molecular epidemiology and management of antimicrobial resistance 82
Correlates and predictive value of early HCV-RNA kinetic during antiviral treatment 82
Comunicazione orale: Embolia maggiore nell’endocardite infettiva: associazione con l’età e la risposta di fase acuta 82
Prevalence of pro-thrombotic genetic polymorphisms in infective endocarditis 82
Inherited Hyper-Homocysteinemia as a Cause of Non-Bacterial Thrombotic Endocarditis 82
Anthropometric parameters and liver histology influence lipid metabolic changes in HCV chronic hepatitis on direct-acting antiviral treatment 82
Totale 9.528
Categoria #
all - tutte 114.200
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 114.200


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.415 0 0 0 0 0 8 310 271 23 368 292 143
2021/20221.878 71 15 9 31 686 13 29 58 62 87 151 666
2022/20233.795 368 57 22 331 381 327 25 260 1.814 36 83 91
2023/20241.621 144 45 67 90 595 136 54 74 10 20 156 230
2024/20255.351 14 55 54 159 783 701 554 569 610 1.191 403 258
2025/20269.841 699 881 1.032 1.145 1.678 4.406 0 0 0 0 0 0
Totale 28.371